EOM Pharmaceutical Holdings Inc (IMUC)
0.1840
+0.03
(+18.68%)
USD |
OTCM |
May 03, 16:00
EOM Pharmaceutical Holdings Max Drawdown (5Y): 99.96% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.96% |
March 31, 2024 | 99.96% |
February 29, 2024 | 99.96% |
January 31, 2024 | 99.96% |
December 31, 2023 | 99.97% |
November 30, 2023 | 99.97% |
October 31, 2023 | 99.97% |
September 30, 2023 | 99.97% |
August 31, 2023 | 99.97% |
July 31, 2023 | 99.97% |
June 30, 2023 | 99.97% |
May 31, 2023 | 99.97% |
April 30, 2023 | 99.97% |
March 31, 2023 | 99.97% |
February 28, 2023 | 99.97% |
January 31, 2023 | 99.97% |
December 31, 2022 | 99.97% |
November 30, 2022 | 99.97% |
October 31, 2022 | 99.97% |
September 30, 2022 | 99.97% |
August 31, 2022 | 99.97% |
July 31, 2022 | 99.97% |
June 30, 2022 | 99.97% |
May 31, 2022 | 99.97% |
April 30, 2022 | 99.97% |
Date | Value |
---|---|
March 31, 2022 | 99.97% |
February 28, 2022 | 99.97% |
January 31, 2022 | 99.97% |
December 31, 2021 | 99.97% |
November 30, 2021 | 99.97% |
October 31, 2021 | 99.97% |
September 30, 2021 | 99.97% |
August 31, 2021 | 99.97% |
July 31, 2021 | 99.97% |
June 30, 2021 | 99.97% |
May 31, 2021 | 99.97% |
April 30, 2021 | 99.97% |
March 31, 2021 | 99.97% |
February 28, 2021 | 99.97% |
January 31, 2021 | 99.97% |
December 31, 2020 | 99.97% |
November 30, 2020 | 99.97% |
October 31, 2020 | 99.97% |
September 30, 2020 | 99.97% |
August 31, 2020 | 99.97% |
July 31, 2020 | 99.97% |
June 30, 2020 | 99.97% |
May 31, 2020 | 99.97% |
April 30, 2020 | 99.97% |
March 31, 2020 | 99.97% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.96%
Minimum
Apr 2024
99.97%
Maximum
May 2019
99.97%
Average
99.97%
Median
May 2019
Max Drawdown (5Y) Benchmarks
CEL-SCI Corp | 96.13% |
AIM ImmunoTech Inc | 99.76% |
IGC Pharma Inc | 97.77% |
NovaBay Pharmaceuticals Inc | 99.91% |
Protalix BioTherapeutics Inc | 94.35% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -9.666 |
Beta (5Y) | 0.2807 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 107.2% |
Historical Sharpe Ratio (5Y) | -0.061 |
Historical Sortino (5Y) | -0.1347 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.97% |